Peptron Inc
KOSDAQ:087010
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Peptron Inc
KOSDAQ:087010
|
KR |
|
Horizon Gold Ltd
ASX:HRN
|
AU |
|
A
|
Atour Lifestyle Holdings Ltd
NASDAQ:ATAT
|
CN |
|
P
|
People's United Financial Inc
LSE:0KH6
|
US |
|
C
|
Chipotle Mexican Grill Inc
XETRA:C9F
|
US |
|
P
|
Pihlajalinna Oyj
OMXH:PIHLIS
|
FI |
|
M
|
Maezawa Kasei Industries Co Ltd
TSE:7925
|
JP |
|
Ascentech KK
TSE:3565
|
JP |
|
G
|
General Commercial and Industrial SA
ATHEX:GEBKA
|
GR |
|
A
|
Amata Corporation PCL
SET:AMATA
|
TH |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
Nomura Holdings Inc
TSE:8604
|
JP |
|
Victoria Oil & Gas PLC
LSE:VOG
|
UK |
|
Savencia SA
PAR:SAVE
|
FR |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
CN |
|
S
|
Sunrise Real Estate Group Inc
OTC:SRRE
|
CN |
|
K
|
Kumpulan Jetson Bhd
KLSE:JETSON
|
MY |
|
Dredging Corporation of India Ltd
NSE:DREDGECORP
|
IN |
|
M
|
Martifer SGPS SA
ELI:MAR
|
PT |
|
E
|
Embpar Participacoes SA
BOVESPA:EPAR3
|
BR |
|
Tecnon Electronics Co Ltd
SZSE:300650
|
CN |
|
Rite Aid Corp
OTC:RADCQ
|
US |
|
W
|
Wuxi Online Offline Communication Information Technology Co Ltd
SZSE:300959
|
CN |
|
SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
|
CN |
Peptron Inc
Peptron Inc., a biotechnology firm based in South Korea, is weaving a narrative of innovation that marries cutting-edge research with real-world applications. Founded in 1997, the company has carved a niche in the realm of peptide-based pharmaceuticals, focusing on the formulation and delivery of these potent compounds for chronic diseases. Central to its story is the SmartDepot™ technology, a proprietary drug delivery system that ensures precise, sustained release of medication. This technology not only enhances patient compliance by reducing the frequency of dosing but also maximizes therapeutic efficacy, positioning Peptron as a trailblazer in improving patient care.
At the heart of Peptron's business model is its ability to capitalize on its advanced drug delivery systems by collaborating with global pharmaceutical giants and seeking strategic partnerships. With a robust pipeline, including promising treatments for Parkinson's disease and various endocrine disorders, Peptron generates revenue through licensing deals, co-development agreements, and the eventual commercialization of its therapeutics. By balancing research innovation with savvy business collaborations, Peptron is not just navigating the competitive biotech landscape; it is rewriting the narrative on harnessing technology for transformative healthcare solutions.
Peptron Inc., a biotechnology firm based in South Korea, is weaving a narrative of innovation that marries cutting-edge research with real-world applications. Founded in 1997, the company has carved a niche in the realm of peptide-based pharmaceuticals, focusing on the formulation and delivery of these potent compounds for chronic diseases. Central to its story is the SmartDepot™ technology, a proprietary drug delivery system that ensures precise, sustained release of medication. This technology not only enhances patient compliance by reducing the frequency of dosing but also maximizes therapeutic efficacy, positioning Peptron as a trailblazer in improving patient care.
At the heart of Peptron's business model is its ability to capitalize on its advanced drug delivery systems by collaborating with global pharmaceutical giants and seeking strategic partnerships. With a robust pipeline, including promising treatments for Parkinson's disease and various endocrine disorders, Peptron generates revenue through licensing deals, co-development agreements, and the eventual commercialization of its therapeutics. By balancing research innovation with savvy business collaborations, Peptron is not just navigating the competitive biotech landscape; it is rewriting the narrative on harnessing technology for transformative healthcare solutions.
